Study of Safety and Efficacy of BCL201 and Idelalisib in Patients With FL and MCL
Clinical trial NCT02603445 · COMPLETED
Trial details
- NCT number
- NCT02603445
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-16
- Primary completion
- 2018-07-10
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.